Home > PE Ratio > KIMIA BIOSCIENCES

KIMIA BIOSCIENCES
PE (Price/Earnings) Ratio

The Current P/E Ratio of KIMIA BIOSCIENCES is 76.14.

Share Price ₹46.7Dec 03,2024
Market Cap ₹220.7 Cr
Earnings-TTM₹2.9 CrTTM-Standalone Results
Price/Earnings76.14xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for KIMIA BIOSCIENCES
Please provide your vote to see the results
KIMIA BIOSCIENCES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of KIMIA BIOSCIENCES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of KIMIA BIOSCIENCES is calculated as :

Current Market Cap [ ₹220.7 Cr] as on Dec 03,2024

(/) Earnings [ ₹2.9 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 76.14x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for KIMIA BIOSCIENCES , the investors are currently willing to pay 76.14 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KIMIA BIOSCIENCES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of KIMIA BIOSCIENCES over the last five years.

Historical PE (Price/Earnings) ratio chart of KIMIA BIOSCIENCES


PE Ratio Performance Analysis for KIMIA BIOSCIENCES

- KIMIA BIOSCIENCES 's latest p/e ratio is 76.14x.

- KIMIA BIOSCIENCES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 23.16x.

- KIMIA BIOSCIENCES 's operated at median p/e ratio of 13.46x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KIMIA BIOSCIENCES 's p/e ratio peaked in Mar2020 at 67.14x.

- KIMIA BIOSCIENCES 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does KIMIA BIOSCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
KIMIA BIOSCIENCES 2.9076.14220.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.75431,544.0
CIPLA LTD4,485.2227.63123,920.0
DR REDDYS LABORATORIES LTD5,406.8018.91102,224.0
ZYDUS LIFESCIENCES LTD4,298.9022.9998,832.3
DIVIS LABORATORIES LTD1,836.0089.80164,865.0
MANKIND PHARMA LTD2,124.8648.25102,527.0
TORRENT PHARMACEUTICALS LTD1,802.0063.14113,772.0
LUPIN LTD2,651.9435.8194,953.0
AUROBINDO PHARMA LTD3,598.8320.4473,544.0
ABBOTT INDIA LTD1,284.6647.0560,440.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KIMIA BIOSCIENCES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.91x
Max industry PE 89.80x
Median industry PE 38.75x
Average industry PE 44.44x



You may also like the below Video Courses